Home Tools
Log in
Cart

Ruxolitinib (S enantiomer)

Catalog No. T6156   CAS 941685-37-6
Synonyms: S-Ruxolitinib, Ruxolitinib S enantiomer, INCB018424, INCB18424

Ruxolitinib S enantiomer (INCB18424) is the S-enantiomer of Ruxolitinib. Ruxolitinib is the first potent, selective JAK1/2 inhibitor.

All products from TargetMol are for Research Use Only. Not for Human or Veterinary or Therapeutic Use.
Ruxolitinib (S enantiomer) Chemical Structure
Ruxolitinib (S enantiomer), CAS 941685-37-6
Pack Size Availability Price/USD Quantity
5 mg In stock $ 58.00
10 mg In stock $ 68.00
50 mg In stock $ 117.00
100 mg In stock $ 157.00
1 mL * 10 mM (in DMSO) In stock $ 58.00
Bulk Inquiry
Get quote
Select Batch  
Purity: 99.79%
Purity: 99.5%
Contact us for more batch information
Biological Description
Chemical Properties
Storage & Solubility Information
Description Ruxolitinib S enantiomer (INCB18424) is the S-enantiomer of Ruxolitinib. Ruxolitinib is the first potent, selective JAK1/2 inhibitor.
Targets&IC50 JAK2 (cell-free assay):2.8 nM, TYK2 (Cell-free assay):19 nM, JAK1 (cell-free assay):3.3 nM
In vitro INCB018424 (180 mg/kg, orally, twice daily) significantly reduced spleen enlargement and the circulation of inflammatory cytokines in a JAK2V617F-driven mouse model, preferentially targeting and eliminating tumor cells, notably prolonging survival without causing bone marrow suppression or immunosuppression. The survival rate exceeded 90% on Day 22 for these mice. Additionally, in myelofibrosis patients, a 15 mg dosage of Ruxolitinib administered twice daily for 48 weeks resulted in at least a 35% reduction in spleen volume in 28% of patients. Patients in the Ruxolitinib group experienced an overall improvement in quality of life and a reduction in symptoms associated with myelofibrosis.
In vivo INCB018424 significantly induces apoptosis in Ba/F3 cells in a dose-dependent manner and effectively and selectively inhibits JAK2V617F-mediated signaling and proliferation in both Ba/F3 and HEL cells. At a concentration of 64 nM, INCB018424 doubles mitochondrial depolarization in Ba/F3 cells. It inhibits the proliferation of erythroid progenitor cells derived from both healthy donors and patients with polycythemia vera, with IC50 values of 407 nM and 223 nM, respectively. Furthermore, INCB018424 demonstrates potent activity in inhibiting the formation of erythroid colonies, with an IC50 of 67 nM.
Kinase Assay Recombinant proteins expressed with Sf21 cells and baculovirus vectors are purified with affinity chromatography. JAK kinase assay is done by a homogeneous time-resolved fluorescence assay with the peptide substrate (-EQEDEPEGDYFEWLE). Each enzyme reaction is carried out with Ruxolitinib or control, JAK enzyme, 500 nM peptide, adenosine triphosphate (ATP; 1 mM), and 2% dimethyl sulfoxide (DMSO) for 1 hour. IC50 is the INCB018424 concentration required for inhibition of 50% of the fluorescent signal.
Cell Research Cell lines: Ba/F3 and HEL cells. Concentrations: 3 μM. Method: Cells are seeded at 2×103/well of white bottom 96-well plates,treated with INCB018424 from DMSO stocks (0.2% final DMSO concentration),and incubated for 48 hours at 37 ℃ in an atmosphere containing 5% CO2.Viability is measured by cellular ATP determination using the Cell-Titer Glo luciferase reagent or viable cell counting.Values are transformed to percent inhibition relative to vehicle control,and IC50 curves are fitted according to nonlinear regression analysis of the data using PRISM GraphPad.
Animal Research Animal Models: JAK2V617F-driven mouse modelFormulation & . Dosages: 5% dimethyl acetamide,0.5% methylcellulose.180 mg/kg. Administration: Oral gavage
Synonyms S-Ruxolitinib, Ruxolitinib S enantiomer, INCB018424, INCB18424
Molecular Weight 306.36
Formula C17H18N6
CAS No. 941685-37-6

Storage

Powder: -20°C for 3 years | In solvent: -80°C for 1 year

Solubility Information

DMSO: 57 mg/mL (186 mM)

Ethanol: 57 mg/mL (186 mM)

H2O: 5 mg/mL (16.32 mM)

TargetMolReferences and Literature

1. Quintas-Cardama A, et al. Blood, 2010, 115(15), 3109-3117. 2. Verstovsek S, et al. N Engl J Med, 2012, 366(9), 799-807. 3. Harrison C, et al. N Engl J Med, 2012, 366(9), 787-798.

Related compound libraries

This product is contained In the following compound libraries:
Inhibitor Library Anti-Cancer Approved Drug Library Anti-Cancer Drug Library Tyrosine Kinase Inhibitor Library Anti-Cancer Clinical Compound Library Drug Repurposing Compound Library Approved Drug Library Anti-Aging Compound Library Kinase Inhibitor Library Bioactive Compound Library

Related Products

Related compounds with same targets
Vidarabine Brepocitinib Hypericin Filgotinib NVP-AEW541 GLPG0634 analog HNMPA-(AM)3 Ibrutinib

TargetMolDose Conversion

You can also refer to dose conversion for different animals. More

TargetMol In vivo Formulation Calculator (Clear solution)

Step One: Enter information below
Dosage
mg/kg
Average weight of animals
g
Dosing volume per animal
ul
Number of animals
Step Two: Enter the in vivo formulation
% DMSO
%
% Tween 80
% ddH2O
Calculate Reset

TargetMolCalculator

Molarity Calculator
Dilution Calculator
Reconstitution Calculation
Molecular Weight Calculator
=
X
X

Molarity Calculator allows you to calculate the

  • Mass of a compound required to prepare a solution of known volume and concentration
  • Volume of solution required to dissolve a compound of known mass to a desired concentration
  • Concentration of a solution resulting from a known mass of compound in a specific volume
See Example

An example of a molarity calculation using the molarity calculator
What is the mass of compound required to make a 10 mM stock solution in 10 ml of water given that the molecular weight of the compound is 197.13 g/mol?
Enter 197.13 into the Molecular Weight (MW) box
Enter 10 into the Concentration box and select the correct unit (millimolar)
Enter 10 into the Volume box and select the correct unit (milliliter)
Press calculate
The answer of 19.713 mg appears in the Mass box

X
=
X

Calculator the dilution required to prepare a stock solution

Calculate the dilution required to prepare a stock solution
The dilution calculator is a useful tool which allows you to calculate how to dilute a stock solution of known concentration. Enter C1, C2 & V2 to calculate V1.

See Example

An example of a dilution calculation using the Tocris dilution calculator
What volume of a given 10 mM stock solution is required to make 20ml of a 50 μM solution?
Using the equation C1V1 = C2V2, where C1=10 mM, C2=50 μM, V2=20 ml and V1 is the unknown:
Enter 10 into the Concentration (start) box and select the correct unit (millimolar)
Enter 50 into the Concentration (final) box and select the correct unit (micromolar)
Enter 20 into the Volume (final) box and select the correct unit (milliliter)
Press calculate
The answer of 100 microliter (0.1 ml) appears in the Volume (start) box

=
/

Calculate the volume of solvent required to reconstitute your vial.

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial.
Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

g/mol

Enter the chemical formula of a compound to calculate its molar mass and elemental composition

Tip: Chemical formula is case sensitive: C10H16N2O2 c10h16n2o2

Instructions to calculate molar mass (molecular weight) of a chemical compound:
To calculate molar mass of a chemical compound, please enter its chemical formula and click 'Calculate'.
Definitions of molecular mass, molecular weight, molar mass and molar weight:
Molecular mass (molecular weight) is the mass of one molecule of a substance and is expressed n the unified atomic mass units (u). (1 u is equal to 1/12 the mass of one atom of carbon-12)
Molar mass (molar weight) is the mass of one mole of a substance and is expressed in g/mol.

bottom

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.

Keywords

Ruxolitinib (S enantiomer) 941685-37-6 Angiogenesis Chromatin/Epigenetic JAK/STAT signaling Stem Cells Tyrosine Kinase/Adaptors Tyrosine Kinases JAK S-Ruxolitinib S-INCB18424 Ruxolitinib INCB 018424 Ruxolitinib S enantiomer INCB-18424 INCB-018424 INCB018424 Janus kinase inhibit INCB 18424 Inhibitor INCB18424 inhibitor

 

TargetMol